ADC Therapeutics Announces Strategic Reorganization to Drive Growth
ADC Therapeutics SA, a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), announced a strategic reorganization to focus resources behind key value-driving initiatives in support of the ZYNLONTA (loncastuximab tesirine-lpyl) franchise. As part of the reorganization, ADC Therape…
